Antibodies against tissue factor pathway inhibitor

The invention relates to antibodies that specifically bind to tissue factor pathway inhibitor (TFPI) and that reduce the clotting time of blood. Such antibodies have utility in the treatment of subjects with a coagulopathy.

Saved in:
Bibliographic Details
Main Authors Krogh, Berit Olsen, Breinholt, Jens, Olsen, Ole Hvilsted, Lauritzen, Brian, Clausen, Jes Thorn, Hilden, Ida, Sorensen, Brit Binow
Format Patent
LanguageEnglish
Published 18.04.2024
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to antibodies that specifically bind to tissue factor pathway inhibitor (TFPI) and that reduce the clotting time of blood. Such antibodies have utility in the treatment of subjects with a coagulopathy.
Bibliography:Application Number: AU20090331570